Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Summary
The global Human Growth Hormone Drugs market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Human Growth Hormone Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Human Growth Hormone Drugs market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Human Growth Hormone Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
